Domenico Accili, MD

Overview

Dr. Domenico Accili is Professor of Medicine at Columbia University and Director of the Columbia University Diabetes and Endocrinology Research Center in New York City. A graduate of the University of Rome, his training in Internal Medicine was served at the University Hospital Gemelli, also in Rome. Following a Fogarty Fellowship in the Diabetes Branch of the National Institute of Diabetes and Digestive Kidney Diseases, he became Chief of the Section on Genetics and Hormone action of the National Institute of Child Health at the National Institutes of Health in Bethesda, Maryland. Since 1999, he has served on the faculty at Columbia University College of Physicians & Surgeons and as an Attending Physician at Columbia-Presbyterian Hospital.&

Areas of Expertise / Conditions Treated

  • Diabetes
  • Research Studies

Academic Appointments

  • Russell Berrie Foundation Professor of Diabetes (in Medicine)

Gender

  • Male

Credentials & Experience

Education & Training

  • University of Cattolica, Italy
  • Fellowship: National Institutes of Health

Honors & Awards

  •     Association of American Physicians
  •     American Society for Clinical Investigation
  •     Member, Metabolism Study Section
  •     Advisory Board, NIDDK Beta Cell Biology Consortium
  •     Advisory Board, Congressional Special Statutory Funding Program for Type 1 Diabetes Research
  •     Molecular and Cellular Endocrinology Study Section
  •     Chair, Beta Cell Group, Diabetes Research Strategic Plan, NIDDK
  •     Member, NIDDK Council
  •     MERIT Award, NIDDK, NIH

Research

Dr. Accili's research has delved into the pathogenesis of diabetes, the integrated physiology of insulin action and mechanisms of pancreatic beta dysfunction. He is best known for the identification of a family of DNA-binding proteins that collectively regulate diverse pathophysiological processes, including liver glucose and lipid production, food intake, insulin production and adipogenesis. He has received numerous awards, including the 2003 Lilly Award for Outstanding Scientific Achievement by the American Diabetes Association. His work has been published in leading medical research journals. He has served on several editorial boards, including the Journal of Clinical Investigation and Diabetes. He is a member of numerous advisory panels for academia, government and industry. He is an elected member of the Association of American Physicians and the American Society for Clinical Investigation. His work is supported by the National Institutes of Health, the American Diabetes Association, the Russ Berrie Foundation, and the Brehm Coalition.

Research Interests

  • Mechanism of insulin action and pathogenesis of diabetes, focusing on pancreatic beta cell failure